Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo.
Ying LuZe-Hui LiuYing-Xiang LiHui-Ling XuWei-Huan FangFang He
Published in: International journal of nanomedicine (2022)
This study described the potential of DC-binding peptides for further improved antigen delivery and vaccine efficacy, explainning nanovaccine optimization in relation to a range of emerging and circulating infectious pathogens.